96 related articles for article (PubMed ID: 35796239)
1. Reduction of heart failure guideline-directed medication during hospitalization: prevalence, risk factors, and outcomes.
Palin V; Drozd M; Garland E; Malik A; Straw S; McGinlay M; Simms A; Gatenby VK; Sengupta A; Levelt E; Witte KK; Kearney MT; Cubbon RM
ESC Heart Fail; 2022 Oct; 9(5):3298-3307. PubMed ID: 35796239
[TBL] [Abstract][Full Text] [Related]
2. Racial Differences in Trends and Prognosis of Guideline-Directed Medical Therapy for Heart Failure with Reduced Ejection Fraction: the Atherosclerosis Risk in Communities (ARIC) Surveillance Study.
Mathews L; Ding N; Sang Y; Loehr LR; Shin JI; Punjabi NM; Bertoni AG; Crews DC; Rosamond WD; Coresh J; Ndumele CE; Matsushita K; Chang PP
J Racial Ethn Health Disparities; 2023 Feb; 10(1):118-129. PubMed ID: 35001343
[TBL] [Abstract][Full Text] [Related]
3. Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: An analysis from the HELP-HF registry.
Tomasoni D; Pagnesi M; Colombo G; Chiarito M; Stolfo D; Baldetti L; Lombardi CM; Adamo M; Maggi G; Inciardi RM; Loiacono F; Maccallini M; Villaschi A; Gasparini G; Montella M; Contessi S; Cocianni D; Perotto M; Barone G; Merlo M; Cappelletti AM; Rosano G; Sinagra G; Pini D; Savarese G; Metra M
Eur J Heart Fail; 2024 Feb; 26(2):327-337. PubMed ID: 37933210
[TBL] [Abstract][Full Text] [Related]
4. Impact of Pharmacist-Led Heart Failure Clinic on Optimization of Guideline-Directed Medical Therapy (PHARM-HF).
Patil T; Ali S; Kaur A; Akridge M; Eppes D; Paarlberg J; Parashar A; Jarmukli N
J Cardiovasc Transl Res; 2022 Dec; 15(6):1424-1435. PubMed ID: 35501544
[TBL] [Abstract][Full Text] [Related]
5. Sex Disparities in Longitudinal Use and Intensification of Guideline-Directed Medical Therapy Among Patients With Newly Diagnosed Heart Failure With Reduced Ejection Fraction.
Sumarsono A; Xie L; Keshvani N; Zhang C; Patel L; Alonso WW; Thibodeau JT; Fonarow GC; Van Spall HGC; Messiah SE; Pandey A
Circulation; 2024 Feb; 149(7):510-520. PubMed ID: 38258605
[TBL] [Abstract][Full Text] [Related]
6. Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases.
Kruik-Kollöffel WJ; van der Palen J; Doggen CJM; van Maaren MC; Kruik HJ; Heintjes EM; Movig KLL; Linssen GCM
PLoS One; 2020; 15(12):e0244231. PubMed ID: 33351823
[TBL] [Abstract][Full Text] [Related]
7. Medical therapy following hospitalization for heart failure with reduced ejection fraction and association with discharge to long-term care: a cross-sectional analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) population.
Levitan EB; Van Dyke MK; Chen L; Durant RW; Brown TM; Rhodes JD; Olubowale O; Adegbala OM; Kilgore ML; Blackburn J; Albright KC; Safford MM
BMC Cardiovasc Disord; 2017 Sep; 17(1):249. PubMed ID: 28915854
[TBL] [Abstract][Full Text] [Related]
8. Guideline-Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure.
Tran RH; Aldemerdash A; Chang P; Sueta CA; Kaufman B; Asafu-Adjei J; Vardeny O; Daubert E; Alburikan KA; Kucharska-Newton AM; Stearns SC; Rodgers JE
Pharmacotherapy; 2018 Apr; 38(4):406-416. PubMed ID: 29423950
[TBL] [Abstract][Full Text] [Related]
9. Timing and Causes of Readmission After Acute Heart Failure Hospitalization-Insights From the Heart Failure Network Trials.
Vader JM; LaRue SJ; Stevens SR; Mentz RJ; DeVore AD; Lala A; Groarke JD; AbouEzzeddine OF; Dunlay SM; Grodin JL; Dávila-Román VG; de Las Fuentes L
J Card Fail; 2016 Nov; 22(11):875-883. PubMed ID: 27133201
[TBL] [Abstract][Full Text] [Related]
10. Pharmaco-disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries.
Averbuch T; Esfahani M; Khatib R; Kayima J; Miranda JJ; Wadhera RK; Zannad F; Pandey A; Van Spall HGC
ESC Heart Fail; 2023 Oct; 10(5):3152-3163. PubMed ID: 37646297
[TBL] [Abstract][Full Text] [Related]
11. Geographic Variation in the Quality of Heart Failure Care Among U.S. Veterans.
Kosaraju RS; Fonarow GC; Ong MK; Heidenreich PA; Washington DL; Wang X; Ziaeian B
JACC Heart Fail; 2023 Nov; 11(11):1534-1545. PubMed ID: 37542510
[TBL] [Abstract][Full Text] [Related]
12. Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial.
Khan MS; Singh S; Segar MW; Usman MS; Keshvani N; Ambrosy AP; Fiuzat M; Van Spall HGC; Fonarow GC; Zannad F; Felker GM; Januzzi JL; O'Connor C; Butler J; Pandey A
JACC Heart Fail; 2023 Nov; 11(11):1507-1517. PubMed ID: 37115133
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Long-Term Mortality and Frequent Re-Hospitalization in Patients with Acute Decompensated Heart Failure and Kidney Dysfunction Treated with Renin-Angiotensin System Blockers.
Baydemir C; Ural D; Karaüzüm K; Balci S; Argan O; Karaüzüm I; Kozdağ G; Ağır AA
Med Sci Monit; 2017 Jul; 23():3335-3344. PubMed ID: 28690311
[TBL] [Abstract][Full Text] [Related]
14. Optimal Heart Failure Medical Therapy and Mortality in Survivors of Cardiogenic Shock: Insights From the FRENSHOCK Registry.
Matsushita K; Delmas C; Marchandot B; Roubille F; Lamblin N; Leurent G; Levy B; Elbaz M; Champion S; Lim P; Schneider F; Khachab H; Carmona A; Trimaille A; Bourenne J; Seronde MF; Schurtz G; Harbaoui B; Vanzetto G; Biendel C; Labbe V; Combaret N; Mansourati J; Filippi E; Maizel J; Merdji H; Lattuca B; Gerbaud E; Bonnefoy E; Puymirat E; Bonello L; Morel O
J Am Heart Assoc; 2024 Mar; 13(5):e030975. PubMed ID: 38390813
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Midodrine on Guideline-Directed Medical Therapy in Patients Admitted With Systolic Heart Failure.
Scoma CB; Lee DH; Money D; Eichelberger G; Usmani A; Cohen AJ; Fernandez J
J Cardiovasc Pharmacol; 2024 Apr; 83(4):353-358. PubMed ID: 38127885
[TBL] [Abstract][Full Text] [Related]
16. A dose-response relationship of renin-angiotensin system blockers and beta-blockers in patients with acute heart failure syndrome: a nationwide prospective cohort study.
Kim KA; Kim ES; Youn JC; Lee HS; Jeon S; Lee HY; Cho HJ; Choi JO; Jeon ES; Lee SE; Kim MS; Kim JJ; Hwang KK; Cho MC; Chae SC; Kang SM; Choi DJ; Yoo BS; Kim KH; Oh BH; Baek SH
Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(6):587-599. PubMed ID: 35088082
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Guideline-Directed Medical Therapy for Outpatients Living with Heart Failure with Reduced Ejection Fraction.
McVannel T; Albers L; Kosar L; Reid B; Yeung C; Siddiqui M; Baran O
Can J Hosp Pharm; 2024; 77(1):e3373. PubMed ID: 38482388
[TBL] [Abstract][Full Text] [Related]
18. Virtual Care Team Guided Management of Patients With Heart Failure During Hospitalization.
Bhatt AS; Varshney AS; Moscone A; Claggett BL; Miao ZM; Chatur S; Lopes MS; Ostrominski JW; Pabon MA; Unlu O; Wang X; Bernier TD; Buckley LF; Cook B; Eaton R; Fiene J; Kanaan D; Kelly J; Knowles DM; Lupi K; Matta LS; Pimentel LY; Rhoten MN; Malloy R; Ting C; Chhor R; Guerin JR; Schissel SL; Hoa B; Lio CH; Milewski K; Espinosa ME; Liu Z; McHatton R; Cunningham JW; Jering KS; Bertot JH; Kaur G; Ahmad A; Akash M; Davoudi F; Hinrichsen MZ; Rabin DL; Gordan PL; Roberts DJ; Urma D; McElrath EE; Hinchey ED; Choudhry NK; Nekoui M; Solomon SD; Adler DS; Vaduganathan M
J Am Coll Cardiol; 2023 May; 81(17):1680-1693. PubMed ID: 36889612
[TBL] [Abstract][Full Text] [Related]
19. Interventions for Optimization of Guideline-Directed Medical Therapy: A Systematic Review.
Tang AB; Brownell NK; Roberts JS; Haidar A; Osuna-Garcia A; Cho DJ; Bokhoor P; Fonarow GC
JAMA Cardiol; 2024 Apr; 9(4):397-404. PubMed ID: 38381449
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Approach to Patients with Heart Failure with Reduced Ejection Fraction and End-stage Renal Disease.
Inampudi C; Alvarez P; Asleh R; Briasoulis A
Curr Cardiol Rev; 2018 Mar; 14(1):60-66. PubMed ID: 29366423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
